Gastrointestinal adverse effectsincluding nausea, vomiting, diarrhea, constipation, and abdominal painare common and may limit tolerability
-Tng cng h min dch: H tr tng sc khng, tng kh nng min dch
GLP-1 Obesity support app Holistic support through a patients weight-loss Journey We are developing a GLP-1 obesity support app that encourages adherence and sustainable lifestyle changes for patients and provides pharma companies with invaluable real-world data
Recently, another investigation appearing in the journal Retina evaluated how the popular drug impacts the risk of AMD development and progression, specifically among patients with type 2 diabetes
However, its production is reduced, especially in the liver, significantly with age, exposing the body to accelerated aging and associated chronic diseases